MedTrace Logo

HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry

NCT02082886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 193

Last updated 2020-01-29

No results posted yet for this study

Summary

In this registry study the investigators will collect data about patients' disease, treatment, and response to treatment to include in both our local and national databases. These can then be used by investigators to answer questions about cytoreductive surgery/HIPEC such as how well-tolerated or effective it is in specific populations.

Conditions

  • Peritoneal Neoplasms
  • Neoplasm Metastasis
  • Adenocarcinoma
  • Sarcoma

Sponsors & Collaborators

  • Edward-Elmhurst Health System

    lead OTHER

Principal Investigators

  • George I Salti, MD · Edward-Elmhurst Healthcare

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02082886 on ClinicalTrials.gov